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The yeast Candida albicans is an important opportunistic human pathogen. For
C. albicans strain typing or drug susceptibility testing, a single colony recovered
from a patient sample is normally used. This is insufficient when multiple strains are
present at the site sampled. How often this is the case is unclear. Previous studies,
confined to oral, vaginal and vulvar samples, have yielded conflicting results and have
assessed too small a number of colonies per sample to reliably detect the presence
of multiple strains. We developed a next-generation sequencing (NGS) modification
of the highly discriminatory C. albicans MLST (multilocus sequence typing) method,
100+1 NGS-MLST, for detection and typing of multiple strains in clinical samples. In
100+1 NGS-MLST, DNA is extracted from a pool of colonies from a patient sample
and also from one of the colonies. MLST amplicons from both DNA preparations are
analyzed by high-throughput sequencing. Using base call frequencies, our bespoke
DALMATIONS software determines the MLST type of the single colony. If base call
frequency differences between pool and single colony indicate the presence of an
additional strain, the differences are used to computationally infer the second MLST
type without the need for MLST of additional individual colonies. In mixes of previously
typed pairs of strains, 100+1 NGS-MLST reliably detected a second strain. Inferred
MLST types of second strains were always more similar to their real MLST types than
to those of any of 59 other isolates (22 of 31 inferred types were identical to the real
type). Using 100+1 NGS-MLST we found that 7/60 human samples, including three
superficial candidiasis samples, contained two unrelated strains. In addition, at least
one sample contained two highly similar variants of the same strain. The probability
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of samples containing unrelated strains appears to differ considerably between body
sites. Our findings indicate the need for wider surveys to determine if, for some types
of samples, routine testing for the presence of multiple strains is warranted. 100+1
NGS-MLST is effective for this purpose.
Keywords: Candida albicans, next generation-multi locus sequence typing (NGS-MLST), detection of multiple
strains in patient samples, candidemia, endogenous sources of infection, transmission, commensal colonization
INTRODUCTION
The yeast Candida albicans is a frequent commensal colonizer
of humans, but can also cause disease, including life-
threatening candidemia when it reaches the bloodstream in
immunocompromised patients (Kim and Sudbery, 2011).
Disease-causing isolates can originate from the patients’
colonizing strains (Reagan et al., 1990; Brillowska-Dabrowska
et al., 2010) or be acquired from exogenous sources (Schmid
et al., 1995).
Tracking sources of infection, or outbreaks, and decisions
on antifungal therapy can necessitate typing and antifungal
susceptibility testing of C. albicans recovered from patient
samples. Commonly only one isolate per patient sample is
assessed, derived from one of manyC. albicans colonies recovered
from the sample (White et al., 2002; McManus et al., 2012;
Moorhouse et al., 2016). Even though the human body can be
colonized by a variety of strains (Soll et al., 1991) this seemed
justifiable, because the existing literature suggested that presence
of multiple strains at the same site is unusual; when multiple
strains were found, they were usually highly similar variants of
one strain. Three studies, involving a total of 24 oral, vulvar
and vaginal samples, found no evidence of unrelated strains in
the same sample (Hellstein et al., 1993; Le Guennec et al., 1995;
Lockhart et al., 1995). Jacobsen et al. (2008) found unrelated
strains in only 2/32 samples (both oral). More recently, however,
Choo et al. (2017) reported a considerably higher incidence
(23%) of samples with multiple unrelated strains from dentures
and saliva of denture wearers. A possible explanation for the
differences between the latter and the former studies could be
that multiple strains are present in some human samples more
frequently than in others. If so it may be misleading to draw wider
conclusions from the limited range of sample types analyzed to
date. Another limitation of the existing data is that for the vast
majority of samples fewer than 10 colonies were typed. As a result,
strains present at frequencies of 10–20% would often have been
missed.
The existing literature does thus not allow a reliable estimate
of how often multiple strains are present in human samples.
Analyzing only one colony per sample, clinical decisions could,
not infrequently, be based on incomplete information.
We therefore developed a next-generation sequencing (NGS)
modification of the existing highly discriminating C. albicans
multilocus sequence typing (MLST) method (Bougnoux et al.,
2003) for detection and simultaneous typing of multiple
C. albicans strains in patient samples. We then used the method
to estimate how often multiple strains coexist in the same site in
the human body.
MATERIALS AND METHODS
Isolation and Maintenance of Strains
Strains in this study included 60 previously characterized strains
(Supplementary Table S1), chosen (Holland and Schmid, 2005)
to best represent the genotypes of an international collection of
461 DNA fingerprinted commensal and disease-causing isolates,
each derived from a single colony (Schmid et al., 1990, 1992,
1993, 1995, 1999; Soll et al., 1991); all of these strains had only
been briefly cultured after their isolation and had subsequently
been maintained as glycerol stocks at−80◦C. Additional samples
were collected from New Zealand patients diagnosed with
candidemia (Supplementary Table S2), New Zealand mothers
and their infants (Supplementary Table S3) and patients at an
Italian hospital (Supplementary Table S4). Up to 100 C. albicans
colonies, identified on CHROMagarTM Candida (CHROMagar,
France) were combined in glycerol stocks (Ausubel et al., 2014)
which were then stored at −80◦C. Ethical approval for collecting
these samples had been obtained from the New Zealand Multi-
regional Ethics Committee, application number MEC/12/06/059
and from the Ethics Committee of the Università degli Studi di
Milano, application number 32/11.
Generation of Strain Mixtures
To generate DNA samples from combinations of two known
strains, aliquots of glycerol stocks of each strain were plated on
YPD medium (Ausubel et al., 2014) and single colonies from
each strain were picked with sterile toothpicks. Colonies from the
strains were combined in different ratios (90 + 10, 80 + 20, and
50 + 50 colonies), in 1 ml of water. Cells were sedimented by a
5 min spin in a micro-centrifuge at 6000× g and freeze-dried.
DNA Extraction
Genomic DNA was extracted using a Qiagen DNeasy Plant Mini
kit (Qiagen, Bio-Strategy Ltd., Auckland, New Zealand) following
the manufacturer’s instructions. To obtain material for DNA
extraction from single colony isolates and from single colonies
from a patient sample, one colony was used to generate, after
incubation at 30◦C for 24 h, a patch on YPD agar (Ausubel et al.,
2014). Patches were scraped off and ground in liquid nitrogen,
using a pestle and mortar. To obtain Candida cells for DNA
extraction from multiple-colony patient samples, an aliquot of
glycerol stock was plated on YPD medium to create a lawn,
which was then scraped off and ground in liquid nitrogen, using a
pestle and mortar. As starting material for DNA extraction from
artificial mixes of C. albicans strains 300 mg of freeze-dried cells
was ground in liquid nitrogen.
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PCR Amplification of MLST Amplicons
and Sequencing
For each sample seven MLST amplicons were amplified, using
the primers shown in Supplementary Table S5, in a final volume
of 25 µl containing 1 U Taq DNA polymerase (Qiagen), 5 µl
of Q-buffer and 2.5 µl of 10x PCR buffer supplied by the
manufacturer (Qiagen), 12 pmol of each primer, 250 µM of each
dNTP (Roche Diagnostics, Auckland, New Zealand), and 10 ng
DNA. The cycling conditions included an initial incubation for
2 min at 94◦C, followed by 30 cycles of 45 s at 94◦C, 30 s at
55◦C, and 30 s at 72◦C followed by a final 7 min extension
step at 72◦C. Reactions were carried out in an Eppendorf
Mastercycler thermocycler (Eppendorf, Hamburg, Germany).
Five microliters of each PCR reaction was loaded on a 2%
agarose TAE gel to confirm successful amplification (Ausubel
et al., 2014). The seven amplicons from each samples were pooled
(4 µl of each PCR reaction) and the pools were submitted
to New Zealand Genomics Limited (Dunedin, New Zealand)
for a second round of PCR in which sample-specific primers
were used to attach sample-specific barcodes (Nextera XT DNA
Library Preparation kit, Illumina, San Diego, CA, United States)
to the products. Sequencing was carried out an Illumina MiSeq
instrument (≥ 2500 reads for each MLST amplicon in a
sample).
Extraction of MLST Sequence
Information
Sequences were de-multiplexed using both sample-specific
barcode and MLST-locus-specific sequence. Sequences were
processed further using the software DALMATIONS, developed
for this work. DALMATIONS performs the following tasks: For
every sample, reads corresponding to each MLST amplicon are
aligned using an allele sequence of laboratory strain SC5314
(Skrzypek et al., 2006). A quality-filtering step removes primer
sequences as well as any reads that contain indels. The aligned
reads are then used to calculate base call frequencies at each
position of each amplicon. For DNA from a single colony, base
calls are used to determine the MLST genotype. In doing so,
if ≥95% of reads have the same base at a given position it is
considered homozygous; otherwise it is considered heterozygous.
For amplicons prepared from DNA derived from pools of
multiple colonies, the MLST type information is extracted as
follows. Using the previously determined MLST type of the
single colony (sc strain), DALMATION simulates the base
calls associated with a second strain (strain B) present in the
pool, assuming percentages of strain B between 1 and 99%,
in 1% steps. At each iteration it calculates, for each amplicon
position, the base calls associated with the sc strain MLST
type, then uses the residual base calls to assign a genotype to
the inferred second strain, so as to minimize the differences
between observed base calls and expected base calls, based on the
genotype.
The software then identifies the most probable frequency
and genotype of the second strain. It determines which inferred
second strain frequency and genotype results in the lowest
number of instances, across all positions in the seven amplicons,
in which the difference between predicted and actual base calls
is <5%. If there are several iterations that are equal in this
respect, it finds the iteration leading to the smallest sum of
all differences between expected and observed base calls, across
all amplicon positions. In these calculations only informative
positions are considered, i.e., sites at which >5% of the single
colony and/or the pool base calls indicate the presence of a base
different from that present in the SC5314 reference sequence.
When attempting to infer the genotype of a second strain
DALMATIONS is not restricted to assuming that the second
strain is diploid. If, assuming diploidy, no second strain genotype
can be found that reduces the difference between observed base
calls expected base calls to ≤5%, DALMATIONS will explore if a
better fit can be reached by assuming triploidy or tetraploidy at
this position.
When the sequence data for the single colony are inconsistent
with diploidy at a given position, the user is alerted and this
position is not used for automatic inference of the second strain’s
MLST type and frequency. A spreadsheet template (tri9.xsl) is
provided with the software to assist the user to infer which,
if any, ploidy levels > 2 would best explain the data. After
inputting call frequencies and the frequency of the strains
inferred from other loci, the spreadsheet calculates the differences
between observed frequencies and those expected if one or
both strains are aneuploids, with ploidy levels up to 4n at this
locus.
Amplicon sequences are concatenated into one single fasta-
formatted file. For indirectly inferred strains, the fasta header
includes the percentage of colonies the strain is likely to represent
and an unexplained data indicator (UDI) score. DALMATIONS
calculates the latter by multiplying the highest percentage of base
calls not explained at any position with the average percentage
not explained, across all positions. The better the genotype and
percentage of the inferred strain explain the observed base calls,
the lower the UDI score. Manually edited positions (see above)
are not considered in the automatically calculated UDI scores
(in this case the user must calculate the UDI and edit the fasta
heading accordingly). See Supplementary Data Sheet S1 for all
MLST types we determined).
DALMATIONS is an open source software and the code can
be found at github1.
The software Geneious, (Biomatters, Auckland, New Zealand)
was used to calculate the number of differences between
pairs of concatenated sequences and distance matrices. From
these UPGMA dendograms (Sokal and Michener, 1958) were
generated using the software R (R Foundation, Vienna, Austria).
RESULTS
Underlying Principles of 100+1
NGS-MLST
Our aim was to develop a methodology that could detect
the presence of multiple strains in a patient sample and
determine their MLST types. We wanted to do so using base
1https://github.com/dwheelerau/dalmations/
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call frequencies in the thousands of sequence reads per amplicon
generated by NGS (MiSeq; Illumina_Inc, 2017) sequencing of
the seven established C. albicans MLST loci [AAT1a, ACC1,
ADP1, MPIb, SYA1, VPS13, ZWF1b (Bougnoux et al., 2003)] in
DNA extracted from pools of colonies recovered from a patient
sample.
We hypothesized that it should be possible to detect multiple
strains by sequencing amplicons amplified from DNA extracted
from a pool of colonies and comparing their sequences to those
derived from DNA from one of the colonies. If multiple strains
are present in the sample, the pool should contain different
strain-specific versions of each amplicon, and this should be
reflected in base call frequencies. For example, if a sample
contained two strains, one of them homozygous [C. albicans is
diploid (Kim and Sudbery, 2011)] for C in position 279 of the
ACC1 amplicon, the other homozygous for T, with the second
strain accounting for 30% of the colonies recovered from the
sample, then in the pool sequences ∼70% of the base call should
be C and ∼30% should be T. In contrast, base calls for a single
colony should be ∼100% C or ∼100% T (depending on which of
the two strains the single colony represents). If all colonies in the
pool represent one strain, then base call frequencies for pool and
single colony should be virtually identical.
If such comparisons indicated the presence of multiple strains,
the MLST types of the additional strains could be obtained
directly by MLST typing of individual colonies. However,
colonies of different strains often have a similar morphology
and different colonies of the same strain can have different
morphology (Hunter, 1991). Thus, a large number of individual
colonies would need to be MLST typed, which would be labor-
intensive and costly. However, if, in addition to the strain
represented by the single colony (sc strain) only one other strain
(strain B) were present in the sample, it should be possible to
infer strain B’s MLST type and its frequency from the pooled and
single colony sequences by an iterative computational approach.
This would involve assuming different frequencies of the second
strain, and at each frequency testing if a second strain MLST type
can be found that, if the strain were present at this frequency,
would explain the sequencing data.
The process is illustrated in Figure 1. In the example shown,
sequencing of the single colony indicates that one of the strains
(the sc strain) is homozygous for C at one given base in one
MLST amplicon (ACC1 position 291). Of the pooled colony
DNA sequencing reads, 70% indicate a C in this position, 30%
a T. Figure 1A shows the outcome of assessing how well two
assumed frequencies (80 and 60%) of the unknown strain (strain
B), would fit the data. The first (80% frequency of strain B) is a
very poor fit. In contrast, assuming a frequency of the unknown
strain B of 60% explains the observed base calls perfectly,
under the assumption that strain B is heterozygous (CT) at this
position.
For position 291 in ACC1 there exists a second explanation
that matches the data, namely that strain B accounts for 30% and
is T-homozygous (Figure 1B). Which alternative is correct can
be determined because all polymorphic sites in all amplicons are
considered. For position 171 in the SYA1 amplicon, only a strain
B frequency of 60% can explain the data (Figure 1B).
FIGURE 1 | Principle of deducing the frequency and genotypes of two strains
from base calls when sequencing DNA prepared from a mixture of colonies.
(A) Predicted allele frequencies assuming that either 20 or 40% of cells in the
sample were from the strain represented by the directly sequenced colony (sc
strain; CC, i.e., C-homozygous) and assuming three possible genotypes of
strain B (shown on top, above brackets), which are compared to observed
base calls (at position 291 in the ACC1 amplicon; 70% C/30% T; shown on
the left). Contributions of each strain to expected base calls are visualized as
boxes under the genotypes; striped parts of the bars indicate the differences
between expected and observed frequencies. (B) Two possible frequencies of
strain B would explain the pool base calls at ACC1 291, but only one
frequency of strain B (60%) explains the base call frequencies at position 171
in the SYA1 amplicon.
Development of the 100+1 NGS-MLST
Method
We wanted to use the MiSeq platform and combine large
numbers of patient samples in a sequencing run, necessitating
the inclusion of a sample-specific DNA barcode (Illumina_Inc,
2016) in each amplicon. We expected that only a minority of
MiSeq reads would yield>250 bp of good-quality sequence. After
subtracting the combined length of sample barcode and locus-
specific primer sequence, this would be equivalent to ≥190 bp of
informative sequence.
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The informative amplicon sequences analyzed in conventional
MLST are 373–491 bp, and thus too long for polymorphisms
across each MLST locus to be well represented with the
anticipated MiSeq read lengths. We therefore designed new
primers (Supplementary Table S5) to generate amplicons with
343–375 bp informative sequence – a total of 2494 bp across
all amplicons, compared to 2883 bp in conventional MLST
(Bougnoux et al., 2003), and containing 85% of the polymorphic
sites in the seven amplicons used in conventional MLST (as
assessed by counting polymorphic sites in allele sequences in the
C. albicans MLST data base at https://pubmlst.org/calbicans/).
We initially tested the performance of our methodology
on single strains, some of which had been typed previously
by conventional MLST, to assess (i) the impact of reduced
amplicon lengths and of MiSeq sequencing on discriminatory
power, (ii) whether our methodology gave results consistent with
conventional MLST and (iii) how closely base call frequencies
matched theoretical expectations. The latter would be crucial
for detecting heterozygosity, as well as for detecting additional
strains and for inferring their genotypes.
We sequenced the MLST amplicons of 54 unrelated strains
from a set (Supplementary Table S1), chosen to best represent
the genotypes of an international collection of 461 DNA
fingerprinted commensal and disease-causing isolates. The
discriminating power of our method was 0.9944 (in 8/1431
pairwise comparisons two unrelated isolates had the same
MLST type; Supplementary Figure S1 and Supplementary Data
Sheet S2), lower than that reported for the original method
[0.9996 (Tavanti et al., 2005)]. We note that failure to discriminate
between two isolates with our method only occurred if the isolates
belonged to a group of genetically very similar strains [general
purpose-genotype cluster (Schmid et al., 1999), corresponding
to clade 1 (Tavanti et al., 2005) Supplementary Table S1 and
Supplementary Data Sheet S2]. These difficult-to-distinguish
strains comprised 64% of our strain set, but only 37% of the set
used by Tavanti et al. (2005).
Twenty strains in our set had been previously typed by
conventional MLST by Tavanti et al. (2005). Our MLST types
matched theirs with the exception of 18 heterozygous SNPs. For
all of these Sanger sequencing confirmed our results to be correct.
Base call frequencies closely matched theoretical expectations.
We assessed this for all positions in all amplicons in 20 strains
(49594 homozygous and 286 heterozygous sites). At homozygous
sites, on average 99.9% of reads indicated the presence of
the same nucleotide. The lowest frequency, observed for only
one homozygous site, was 95%, and only 189 sites (0.4%)
had frequencies of the predominant nucleotide of ≤97%. For
heterozygous sites, the average difference between the number of
calls expected for one of the two nucleotides present (50%) and
calls observed was 1%. The maximum, observed once, was 3.5%
(i.e., 46.5% of calls were for one base, 53.5% for the other) and
only for 5/286 (1.7%) sites was the difference ≥ 3%.
Two heterozygous sites in one strain were excluded from the
analysis as a 1:3 ratio of bases was observed, reproducibly, at
these sites in the ZWF1b MLST amplicon. Aneuploidy is not
uncommon in C. albicans (Selmecki et al., 2010) and these ratios
indicate that this particular strain has 3 copies of this locus.
The close match of base calls with theoretical expectations
suggested an avenue for lowering the cost and time requirements
of the methodology when is it is not crucial to obtain complete
results immediately, for instance in retrospective studies. Under
such circumstances, rather than immediately typing both a
colony pool and a single colony, initially only DNA prepared
from a colony pool needs to be sequenced. Base call frequencies at
all amplicon positions of either> 95% or 50± 5% would indicate
that the pool represents only a single strain, and that its MLST
type has been accurately captured. Base call frequencies outside
these ranges indicate presence of a second strain and the need to
sequence DNA from a single colony.
We developed software, DALMATIONS, that implemented
the iterative approach for finding a second strain’s frequency
and genotype outlined above. Because of stochastic variations,
base call frequencies will not exactly align with theoretical
expectations, and as a result DALMATIONS cannot infer a strain
B frequency and genotype that perfectly matches the sequencing
data. Rather, it determines which inferred strain B frequency
and genotype results in the lowest number of instances in which
the difference between predicted and actual base calls is <5%.
If there are several iterations that are equal in this respect, it
finds the iteration leading to the smallest sum of all differences
between expectation and observed base calls, across all sites in all
amplicons.
Circumstances might occur, such as sequencing errors or the
presence of >2 strains in the sample, under which the inferred
strain B genotype will be poorly predicted. When reporting
the strain B genotype and its frequency that best matches
the sequencing data, DALMATIONS therefore also provides
an indication of mismatches between inferred genotype and
frequency of strain B and the actual sequencing data. It records
the average percentage of base calls not explained by the reported
strain B genotype and frequency across all informative amplicon
positions (i.e., positions used to infer strain B genotype) and the
highest percentage of base calls at any one position not explained.
It then multiplies the two values and reports the product as a
UDI (unexplained data indicator) score. For example if, averaged
across all positions, 3% of base calls are not explained, and the
highest percentage unexplained at any one position is 5%, then
the UDI is 15 (3× 5).
Accuracy of Inferring, From Base Calls,
MLST Types Present in DNA Pools
Extracted From Artificial Mixtures of
Colonies of Two Strains
We next tested how accurately our 100+1 NGS-MLST method
would infer the frequency and genotype of a second strain in
a sample containing two strains. We did this using artificial
mixtures of pairs of known strains, prepared either in silico by
preparing sequencing read files containing different proportions
of reads obtained from the sequencing of single colonies of two
strains, or by mixing colonies from the strains and extracting
DNA from these mixtures of cells.
In all 13 attempts conducted with in silico mixtures, with
simulated frequencies of the second strain ranging from 6 to 65%,
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the DALMATIONS software reported the presence of a second
strain at a frequency differing by no more than 1% from the
frequency of reads representing the second strain in the mixture
(Figure 2). In only three attempts were the inferred genotypes not
identical to the real genotype (Figure 3). Of the latter, two were
for strains simulated to be present at very low levels (6 and 8%).
All inferred genotypes were closer to the real genotypes than to
those of the 59 other strains from our global collection.
In 18 attempts to deduce the frequency of a second strain in
DNA pools prepared from 10+ 90, 20+ 80, and 50+ 50 colonies
of pairs of strains, the DALMATIONS software again inferred
the numbers of colonies of the strains accurately. The inferred
numbers never differed from the actual number of colonies of
the second strain by more than 11 (average difference 5.3 ± 3.2
colonies; Figure 2). Twelve of 18 inferred second strain genotypes
were an exact match to the actual genotype of the second strain
(Figure 3). One instance in which a genotype was not accurately
inferred was in a sample in which the concentration of the strain’s
DNA was very low (8%), making inferences of its genotype
difficult. In two other cases a high UDI (>15) would have alerted
the user that the inferred genotype may not be reliable (Figure 3).
Only these two UDI scores exceeded 15. Of the remaining 18 UDI
scores most (13 scores) were below 10.
Excluding the two attempts to infer MLST types of strains
present at a frequency < 10%, the differences between the
inferred genotypes and the real genotypes were 3, 6, or 7 base
calls, a small number of differences compared to the typical
number of differences between unrelated strains: Differences
between MLST types of pairs of unrelated strains of ≤3, ≤6,
and ≤7 bases occurred with frequencies of 6, 17, and 19%
respectively (Supplementary Figure S1). More importantly, all
inferred genotypes of second strains inferred from DNA prepared
from colony mixes were more similar to their real genotypes than
to those of 59 other strains included in the analysis.
These experiments indicated that 100+1 NGS-MLST could
accurately infer the frequency of a second strain in a sample and
provide a good approximation of its genotype.
100+1 NGS-MLST Detects Multiple
Unrelated Strains in 7/60 Human
Samples
To further test the methodology and to get a better estimate of
how often human samples contain multiple strains, we used it on
a selection of 60 human samples (Figures 4–7 and Supplementary
Tables S2–S4). Eleven samples were derived from four patients
diagnosed with candidemia in Auckland, New Zealand, another
11 from the oral cavities of 9 healthy women about to give birth
plus two from one of their infants in Dunedin, New Zealand. The
remaining 38 were from non-sterile sites from 17 individuals at
a hospital in Milan, Italy, including samples from sites that were
merely colonized and sites where C. albicans caused disease.
We initially sequenced pooled colony samples (most samples
contained ≥ 100 C. albicans colonies; the lowest number was 41
colonies). We identified 28 samples in which base call frequencies
of 94% – 56% or 6% – 44% suggested the presence of multiple
strains. However, in 21 of these, only one of the seven MLST
FIGURE 2 | Frequencies of strains deduced from mixed samples versus
percentage of reads in in silico artificial pairs (red line of best fit, squares) or
versus the percentage of colonies used to prepare DNA from a mixture of two
strains (blue lines of best fit, circles).
loci had base call frequencies in these ranges, suggesting that, if
two strains were present, one of them would be a closely related
variant of the other, having suffered a loss of heterozygosity
(LOH) at one locus. We subsequently typed a single colony from
9 of these 21 samples. In 8 of these, single colony base calls
indicated> 2n ploidy at the ACC1 locus, consistent with presence
of a single aneuploid strain. In the one remaining sample the
single colony confirmed the presence of two related strains,
differing by an LOH at AAT1. Thus 53/60 samples contained
either a single strain or two variants of one strain, distinguished
by an LOH.
For six of the seven remaining samples, with base call
frequencies in the colony pool of 94% – 56% and 6% – 44% at
multiple loci, we sequenced a single colony to infer the genotype
and frequency of the two strains present. To test the robustness
of our inferences we did so twice, based on two sequencing
runs of DNA from the colony pool. Both attempts gave highly
similar, usually identical, results in terms of inferred genotype
of the second strain (Figure 4). With one exception (sample
Mi16) the two inferred genotypes were more similar to each
other than to any other strain shown in the figure. In all samples
both attempts to estimate the frequencies of the two strains
gave comparable results. Thus inferred genotypes and frequency
estimates were reproducible. For two samples the reliability of
inferred genotypes was supported by the presence of an identical,
or almost identical directly sequenced strain in another sample
from the same individual (Mi11, highlighted in bold in Figure 4).
UDI values for the inferred genotypes (Figure 4) were often
higher than those for inferred genotypes in our artificial pairs
(see above). This could have been an indication that more than
two strains were present in these samples: If three strains are
present in a pool then attempts to infer only one additional
strain would yield a compromise genotype, poorly matching
the data. However, when we investigated the fit of the data for
individual positions in the amplicons, we found that the high
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FIGURE 3 | Similarity between genotypes inferred in artificial mixtures of pairs
of strains and their real genotypes. The UPGMA dendrogram is based on the
number of nucleotide differences between 60 isolates (listed in Supplementary
Table S1) directly determined by sequencing, plus attempts to infer the
genotypes of seven of these strains indirectly (each marked by a different
colored symbol; the strains and their frequencies are shown in the gray box).
Blue-bordered rectangles mark MLST types of strains inferred from mixtures
generated in silico by combining reads from the sequencing of one single
colony of each of two strains (the arrows indicate the single colony strain in
the mixture used to infer the genotype of the other strain from the mixed
sequence). Ovals indicate strains that were inferred from DNA preparations
generated from a mixture of colonies of two strains. Red-bordered symbols
mark the true genotype of the strain we attempted to infer. Percentages
shown next to symbols on the right are the inferred percentages of the inferred
strain when less than 10% of sequences were derived from the inferred strain.
Number in italics are UDI scores (only scores exceeding 25 are shown).
UDIs were caused by base calls at only one or two positions,
usually in ACC1, suggestive of LOH at one locus, amplification
or sequencing errors or highly unusual ploidy (even assuming
triploidy or tetraploidy at this locus did not result in a good match
of predicted and expected base calls). At all other positions base
call frequencies predicted on the basis of the inferred genotypes
closely matched the observed base call frequencies. Thus if a third
FIGURE 4 | UPGMA tree showing differences between MLST types, directly
and indirectly inferred, in six samples containing two unrelated C. albicans
strains. Different samples are distinguished by different colored symbols.
Circles mark the MLST type of the sc strain, i.e., the strain directly determined
by sequencing a single colony. Squares indicate the outcome of two attempts
to indirectly infer the genotype and frequency of the second strain in the
sample. Labels include patient number and site sampled. For indirectly
inferred MLST types this is followed by the estimated percentage of the strain
in the sample and the UDI of the estimate. Strains from candidiasis samples
are marked by red borders. MLST types in two samples from patient Mi11,
both containing the same pair of strains, are highlighted by bold lettering.
FIGURE 5 | UPGMA tree showing MLST types of isolates from four
candidemia patients. Isolates from the same patient are marked by rhombs of
the same color. A red border indicates that the isolate is from a sterile site
(PBC, peripheral blood culture; CBC, catheter blood culture; CT, catheter tip).
Labels include patient number, sampling site and date of isolation. Labels of
two strains in the patient Au2 fecal sample are in bold type and include the
estimated percentages of the two strains.
strain was present at all, it would have been merely an LOH
variant of one of the two strains we identified. Thus each of the
six samples essentially contained two strains.
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FIGURE 6 | UPGMA tree showing MLST types of isolates from 10 patients
who were sampled at different sites on the same day. Isolates from the same
patient are marked by a symbol of the same color. Strains from candidiasis
samples are marked by red borders. Labels include patient number, sampling
site and date of isolation. Brackets mark instances in which multiple isolates
from the same patient have the same (or extremely similar) MLST types.
FIGURE 7 | UPGMA tree based on MLST types of four patients for whom the
same site was sampled on two dates. Strains from candidiasis samples are
marked by red borders. Labels include patient number, sampling site and date
of isolation.
Application of 100+1 NGS-MLST to our set of patient
samples, while not a systematic survey, also provided some
insights into the nature of co-existing strain combinations, the
degree to which different sites may favor coexistence of multiple
distinct strains and in what ratios (Table 1 and Figures 4–7).
Similarity of MLST type does not seem to be a prerequisite for
coexistence: members of each of the six pairs were more similar
to a member of another pair than to the second member of the
pair (Figure 4). In terms of which sites favor co-colonization, we
encountered multiple strains at four of the nine sites we sampled,
with frequencies of the less frequent strain ranging from 18%
to 47% (average 31% ± 13%; Table 1). Our data suggest that
multiple strains are less common in rectal swabs and blood, but
that ∼1/3 of samples from feces, urine and vagina might contain
multiple strains. Of the seven samples with multiple strains, four
were from colonized sites at which C. albicans did not cause
disease symptoms (Au2 fecal, DM6 oral, Mi11 urinary; Mi16
oral). The remaining three were from sites where C. albicans
caused disease (Figure 4), namely oral candidiasis (in Mi1)
and vaginitis (in Mi2 and Mi11), indicating that candidiasis at
non-sterile sites can be caused by combinations of strains. In
Mi11 a urinary tract sample contained the same two strains as
the vaginitis sample and in similar frequencies (Figure 4); this
suggests that a given combination of strains may be successful in
different niches.
We also verified that gaining reliable information about
sources of candidemia requires typing of more than one
colony: In all four Auckland candidemia patients MLST types
at non-sterile sites matched those of a single MLST type in
the bloodstream (Figure 5), indicating colonizing isolates as
the source of candidemia. However, in one patient (Au2) the
colonizing source of the blood strain might have been missed if
only one colony from a fecal sample containing two strains had
been MLST-typed.
Lastly, our samples highlight that different strains are often
present in different non-sterile sites of the same individual and
that the C. albicans flora at a given site can change fairly quickly.
Of 10 patients sampled at different non-sterile sites on the same
day, five carried different strains at different sites (Figure 6) and
strains at a given site were replaced by other strains within 3–
5 months (Figure 7; Mi8 and Mi15; strains did not change over a
shorter periods in Mi2 and Mi7).
DISCUSSION
Our results indicate that human samples do not infrequently
contain multiple C. albicans strains. We found this to be the
case in 7/60 i.e., 12% of samples. However this average may
not be particularly meaningful. Our data indicate that some
types of samples contain multiple strains much more often –
one likely reason for the range of frequencies of such samples
(0–25%) reported in the literature (Hellstein et al., 1993; Le
Guennec et al., 1995; Lockhart et al., 1995; Jacobsen et al.,
2008; Choo et al., 2017). When multiple strains were present in
our samples, one of them often represented less than ¼ of the
cells. This suggests that the low number of colonies sampled in
previous work (Hellstein et al., 1993; Le Guennec et al., 1995;
Lockhart et al., 1995; Jacobsen et al., 2008; Choo et al., 2017)
would have often prevented detection of the presence of multiple
strains.
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TABLE 1 | Frequency of coexistence in different sampling sites.
Site Frequency of multiple strains
Blood 0/7
Eye 0/1
Feces 1/2
Oropharyngeal 3/25
Rectal 0/11
Respiratory 0/1
Skin 0/3
Urine 1/4
Vagina 2/6
All sites 7/60 (12%)
These considerations suggest that wider surveys are needed
to establish how often multiple strains are present in different
types of samples and if in some situations routine testing for
the presence of multiple strains could be warranted. The 100+1
NGS-MLST method is an effective and reliable approach for
doing so. In addition, the method provides accurate estimates of
the frequency of the strains and determines their MLST types –
we have shown that when two strains are present a reasonably
accurate MLST type can usually be inferred indirectly for the
second strain based on the pooled colony sample. We note that
the underlying approach of comparing a single colony and a pool
can, in principle, also be used to detect the presence of multiple
strains using non-sequencing based C. albicans typing methods
such as microsatellites (Sampaio et al., 2005), although it will
probably be harder to deduce the second strain’s genotype and
frequency. Our approach should also have applications in MLST
typing of other pathogens – C. albicans is not the only species
in which multiple strains can coexist in the same host niche
(Cookson et al., 2017).
None of our samples contained more than two unrelated
strains, but in principle it is possible to infer the genotypes of
three strains in a sample using our methodology. One output of
DALMATIONS is a table showing discrepancies between actual
base calls and base calls expected for strain B at each informative
amplicon position (i.e., variable positions used to infer strain B
genotype) at 98 possible strain B1 frequencies (1–99%). If strain
B actually represents two strains (B1 and B2) then there should
be one frequency (F1) at which, for positions at which only B1
differs from the sc strain, expectations and observed base calls are
a close match. There should be another such frequency (F2) for
B2-specific polymorphisms and a third (F3) for polymorphisms
common to B1 and B2 and distinguishing them from the sc strain.
Using these frequencies and the known genotype of the sc strain,
it is possible to infer genotypes and frequencies of all three strains
(a description of the procedure is included in Supplementary
Data Sheet S3).
100+1 NGS-MLST provides more information than
conventional MLST sequencing of one colony per sample,
and at a 40% lower sequencing cost (60% less if single colonies
are only typed if read distribution in a pool indicates the
presence of multiple strains; based on quotes from our local
sequencing facility). Additional savings arise from a reduction
in the number PCR product cleanups undertaken because in
our method this is done for a mixture of all 7 PCR products
for DNA from each colony or colony pool rather than for
each product individually, as required for Sanger sequencing.
The only drawback of 100+1 NGS-MLST is the reduced
amplicon lengths, inherently associated with a reduction in
discriminatory power. However, this is largely compensated by
better reproducibility of typing for two reasons. One is that use
of base call frequencies by 100+1 NGS-MLST is likely to be more
reliable than chromatogram peak height (Odds et al., 2006) in
determining whether a locus is heterozygous. In addition, 100+1
NGS-MLST typing is less affected by changes in MLST type that
can be caused by LOH. C. albicans frequently suffers LOH events
both in the host (Bougnoux et al., 2006) and during laboratory
culture of C. albicans ((Odds et al., 2006); this study, data not
shown). If LOH occurs, a single colony typed by conventional
MLST may represent the LOH-altered MLST type. In contrast
100+NGS-MLST will also detect the original genotype, if it is
still present in part of the culture. Thus our methodology is more
likely than conventional MLST to produce exact matches when
the same strain is present in different samples. As a result, the
reproducibility-adjusted discriminatory power (Hunter, 1991) of
100+1 NGS-MLST may rival or even exceed that of conventional
MLST, at least as far as the MLST type of the directly sequenced
colony is concerned.
Aside from its obvious advantages for assessing origins
of candidemia or antifungal resistance profiles, capturing all
strains in a sample by detecting them with 100+1 NGS-MLST
has other benefits. It enables genomic comparisons that may
identify features that determine the potential of a strain to cause
candidemia in humans – an important opportunity given that
such features cannot be reliably identified in animal models
(Odds et al., 2001; Schmid et al., 2011). Comparing the genomes
of those members of pairs of co-colonizing strains at non-sterile
sites that become etiological agents of candidemia, with those
that do not (such as the two fecal strains in candidemia patient
AU2) may reveal such pathogenicity determinants. Also, we have
recently obtained evidence that the transition of a colonizing
strain into a pathogen could involve mutation of highly mutable
tandem repeat-containing C. albicans open reading frames
[TR-ORFS (Zhou et al., 2017)]. If so, we would expect an
increase in the frequency of virulence-enhancing TR-ORF alleles
during the transition from colonization to disease in otherwise
genetically identical C. albicans cells at the site. 100+1 NGS-
MLST would be ideal for determining whether such shifts in
TR-ORF allele frequency during pathogenesis are caused by
mutation of an existing strain or signal that the disease is caused
by an incoming unrelated strain with different TR-ORF alleles.
Multiple strains were as common in samples from non-sterile
sites at which C. albicans caused disease as in samples from sites
that were merely colonized [one of the few previously described
samples with two unrelated strains was also derived from an oral
candidiasis sample (Jacobsen et al., 2008)]. Thus even though
C. albicans strains apparently differ in their potential to cause
human disease and mortality (Schmid et al., 1999; Odds et al.,
2007; Schmid et al., 2011) competition during pathogenesis does
not necessarily eliminate all but one strain. The same might
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apply to candidemia. However, presumably candidemia usually
involves a bottleneck in that only a small number of cells initially
enter the bloodstream. This would often eliminate one strain
(Kimura and Ohta, 1969) and be one of the reasons why only
one strain tends to be isolated from bloodstream samples (Odds
et al., 2006); we observed the same in our small set of bloodstream
samples.
Our survey adds to the evidence (Soll et al., 1991; Jacobsen
et al., 2008; Choo et al., 2017) that the commensal Candida
microbiome of humans is complex and dynamic, involving
multiple changing strains, sometimes coexisting at the same site.
Commensalism receives less attention than pathogenesis, but
the primary functions of C. albicans virulence factors and the
selective pressures that led to their evolution are most likely
exclusively linked to its commensal lifestyle (Schmid et al.,
1999) – and thus easiest to understand in this context. Using
100+1 NGS-MLST to investigate how strains compete with each
other can thus yield important new insights into C. albicans’
pathogenicity not only when applied to sites of infection, but also
when used on commensal samples.
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